Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
about
Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Erratum to: Clinical Pharmacok ...... Receptor-Neprilysin Inhibitor.
@en
Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
type
label
Erratum to: Clinical Pharmacok ...... Receptor-Neprilysin Inhibitor.
@en
Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
prefLabel
Erratum to: Clinical Pharmacok ...... Receptor-Neprilysin Inhibitor.
@en
Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan
@nl
P2093
P2860
P1476
Erratum to: Clinical Pharmacok ...... Receptor-Neprilysin Inhibitor.
@en
P2093
Gangadhar Sunkara
Parasar Pal
Sreedevi Boggarapu
Surya Ayalasomayajula
Thomas Langenickel
P2860
P2888
P304
P356
10.1007/S40262-017-0558-9
P577
2017-05-19T00:00:00Z